A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
about
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysisTreatment for small cell lung cancer, where are we now?-a reviewThe role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literatureA three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibioticsVAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II studyPhase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancerA phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.Factors influencing treatment selection and survival in advanced lung cancerExtensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms.Available treatment options for the management of Lambert-Eaton myasthenic syndrome.Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Gastric metastasis from small cell lung cancer: a case report.Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysisChemotherapy for small cell lung cancer: a comprehensive reviewSmall Cell Cancer of the Bladder and Prostate: A Retrospective Review from a Tertiary Cancer CenterKi-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysisRandomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.Small cell lung cancer: treatment review.Pemetrexed in small-cell lung cancer: background and review of the ongoing GALES pivotal trial.Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer.Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas.Genitourinary small-cell carcinoma: a single-institution experienceTreatment outcomes of patients with small cell lung cancer without prophylactic cranial irradiation.Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Radiochemotherapy in small-cell lung cancer.Medical treatment of small cell lung cancer: state of the art and new development.Advances in pharmacotherapy of small cell lung cancer.Current challenges of lung cancer care in an aging population.Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1.A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung CancerThe strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.Chemotherapeutic targeting of etoposide to various tissues on the basis of polyamine level.Outcome and prognostic factors in single brain metastases from small-cell lung cancer.Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer.Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen.Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer.Small Cell Lung Cancer.
P2860
Q24800321-0C7DD8DF-FC59-44C0-A2F9-603E71B5E0E9Q26767023-EEDA2C77-EE68-4EDE-BF97-80702284EF12Q28364191-808D2E6F-8712-4DA1-BBE2-048A05CA30B6Q28364853-C53B6601-F9B5-4D6D-BEAF-BFB2367A638AQ28596809-48DFC14C-1FEB-4C3C-BAEB-BAE09CC46B27Q33400292-222C6003-65CB-4593-B790-DBA86F9C22FEQ33416075-5DBE9155-8C67-4756-8966-97333ACAD53BQ33611139-91CA75EE-4A82-452A-91A3-FFEFAB065340Q34252309-902B2E4F-731D-432D-B4A2-2E1D04D05982Q34542581-732341FD-CB62-4033-8D7D-4DBD1485EF9AQ34565988-CCF16BE7-FED9-43F7-846D-395FED1135E1Q34653756-C203C4E8-CDD3-461D-B5F3-C7C59E34AFEDQ35045831-05F6D838-18FA-419E-AD4F-C31E974ADE62Q35167933-DAB04C90-1B51-4A4E-9914-A04DE7B909BEQ35569379-9E49D369-CD03-469B-AD54-D901ADD96F27Q35928857-75F41ADD-6BA0-45FE-9791-21B3B613A38FQ35951523-C79CD790-A525-4B96-9809-2C1497F83FFFQ35984458-37D67BC6-9AA9-4602-8259-D6256E760DFEQ36385818-DB13174B-AECE-424A-B881-777779EA9895Q36458604-BFEF90C4-769A-4ECF-8DC4-BBD968A96236Q36817105-AA2463F2-FEA7-48D4-ADE7-7590B5318B17Q36858092-93E33B63-FC5F-4B42-BA9E-C8B484FAE506Q37015297-42B33A4D-C53C-45D3-9267-9B4DF89450F4Q37246147-33225C2F-5300-4C00-9D09-062D904EAC41Q37247963-549A2330-84CB-4FFD-9048-BFC2A2F9DD60Q37329378-4B6D826F-CD51-445D-90E3-7EA13D14DD16Q37489161-E365602A-3A9F-43AD-B8F4-AD570B169CA2Q37614569-1F8FC685-FEED-4E86-AFCA-0B7B205CCC4FQ38125489-A535C832-D382-46CC-87B8-A3E63126E354Q38254295-A2B2CD27-534C-4D8E-BC9B-2DBDAA66B9E4Q38608627-3D48AA74-2141-4E47-836C-3571EE674797Q39577806-841479AB-D8E6-4DF6-BAF2-FF3B1353E3FEQ41860470-EB36BD61-855E-436B-A4CB-A9577787862FQ44476097-B2F6F398-931C-41D6-BF6F-4E28506A8A6AQ44941788-0939FE03-56D1-4002-90D7-F8BD9E84EBD0Q47994199-4F253D73-0010-4C80-B2F6-31CE9081F1F0Q48286025-AA0FAB90-96F2-4F8A-80BE-648E72547143Q50050385-F840AF05-A747-49E1-9968-91906ED58FAEQ50502921-B8B25D5A-2CAC-4D54-BA5D-365EC57B6AB0Q52853801-323C20E4-584D-4EC9-9A7A-F2BE24E9F77D
P2860
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A systematic review of the rol ...... assessment and meta-analysis.
@ast
A systematic review of the rol ...... assessment and meta-analysis.
@en
A systematic review of the rol ...... assessment and meta-analysis.
@nl
type
label
A systematic review of the rol ...... assessment and meta-analysis.
@ast
A systematic review of the rol ...... assessment and meta-analysis.
@en
A systematic review of the rol ...... assessment and meta-analysis.
@nl
prefLabel
A systematic review of the rol ...... assessment and meta-analysis.
@ast
A systematic review of the rol ...... assessment and meta-analysis.
@en
A systematic review of the rol ...... assessment and meta-analysis.
@nl
P2093
P1433
P1476
A systematic review of the rol ...... assessment and meta-analysis.
@en
P2093
European Lung Cancer Working Party (ELCWP)
F Lemaitre
J J Lafitte
J P Sculier
M Paesmans
P Vermylen
T Berghmans
P356
10.1016/S0169-5002(00)00127-6
P577
2000-10-01T00:00:00Z